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Abstract
Background: Aneuploidy has long been recognized to be associated with cancer. A growing body of evidence
suggests that tumorigenesis, the formation of new tumors, can be attributed to some extent to errors occurring at
the mitotic checkpoint, a major cell cycle control mechanism that acts to prevent chromosome missegregation.
However, so far no statistical model has been available quantify the role aneuploidy plays in determining cancer.
Methods: We develop a statistical model for testing the association between aneuploidy loci and cancer risk in a
genome-wide association study. The model incorporates quantitative genetic principles into a mixture-model
framework in which various genetic effects, including additive, dominant, imprinting, and their interactions, are
estimated by implementing the EM algorithm.
Results: Under the new model, a series of hypotheses tests are formulated to explain the pattern of the genetic
control of cancer through aneuploid loci. Simulation studies were performed to investigate the statistical behavior
of the model.
Conclusions: The model will provide a tool for estimating the effects of genetic loci on aneuploidy abnormality in
genome-wide studies of cancer cells.
Background
In recent years, there has been a wealth of literature on the
development of statistical methods for genetic analysis of
complex diseases, such as cancer [1,2]. These methods,
mostly founded on rigorous statistical theory and models,
have been instrumental in the analysis and modeling of
genetic data, leading to the identification of significant
genetic variants involved in pathogenesis [3,4]. However,
many existing statistical methods neglect biological princi-
ples refreshed and updated from the latest scientific dis-
coveries obtained by using new genomic technologies. A
lack of the integration between statistics and biology will
significantly limit our detection and characterization of the
new genetic underpinnings of a disease. The motivation of
this study is to develop a novel statistical model for detect-
ing the genetic control of cancer through chromosomal
loci predisposing to aneuploidy.
Aneuploidy occurs when an individual has an abnormal
number of chromosomes. Partial or whole chromosomes
may be duplicated or missing in individuals with this
condition. Cytological studies show that aneuploidy is
one of the most pronounced differences between normal
and cancer cells [5]. However, debates have arisen over
how aneuploid cells are produced and whether or not
they are a cause or consequence of tumorigenesis [6,7]. A
growing body of evidence from molecular genetic studies
supports a role of aneuploidy in the genetic underpinning
of cancer [6,8-12]. According to extensive work by Dues-
berg and his group, the impact of aneuploidy on cancer
is embodied in the following aspects:
(1) Aneuploidy is confirmed to generate abnormal
phenotypes, such as Down syndrome in humans and
cancer in animals;
(2) The degree of aneuploidy is correlated with phe-
notype abnormality;
(3) Since aneuploidy imbalances the highly balance-
sensitive components of the spindle apparatus, it
destabilizes symmetrical chromosome segregation;
(4) Both non-genotoxic and genotoxic carcinogens
can cause aneuploidy by physical or chemical inter-
action with mitosis proteins.
Similar to point (2), there is additional evidence that
cancer-specific phenotypes result when aneuploidy
exceeds a certain threshold [13,14]. Kops et al. [15] out-
lined the cytological mechanisms for aneuploid
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formation from checkpoint signalling. Normally, chro-
mosome mis-segregation can be prevented at the mitotic
checkpoint by delaying cell-cycle progression through
mitosis until all chromosomes have successfully made
spindle-microtubule attachments, but a defect in the
mitotic checkpoint can generate aneuploidy, facilitate
tumorigenesis, and can cause increased resistance to
anti-cancer therapies [16].
The statistical model developed to detect cancer genes is
constructed with a random sample of aneuploid patients
with cancer drawn from a natural population. At an aneu-
ploid locus, polyploids occur because of the duplication of
one or two parental chromosomes and, thus, the model
can be formulated to test the genetic imprinting of alleles
due to their different parental origins.
If the aneuploidy hypothesis is continuously con-
firmed, this model will provide a timely tool to quan-
tify the genetic effects of aneuploidy loci on cancer
susceptibility by integrating the genetic data from the
cancer genome project. Also, by comparing with the
model for detecting somatic mutations, this new
model will help to determine the relative importance
of the aneuploidy and mutation hypotheses in cancer
studies.
Methods
Study Design
Suppose there is a normal human diploid population
which is at Hardy-Winerberg equilibrium (HWE). Some
individuals in this population form cancer owing to par-
ticular regions of their chromosomes multiplied to form
a triploid, tetraploid, or a polyploid of any higher order.
To simply describe our model, we only consider a tri-
ploid. As proven below, the population after chromoso-
mal multiplication will deviate from HWE. We assume
that a total of n cancer patients are randomly sampled
from this population. Each sampled patient is a triploid
at a particular aneuploid locus. We genotype all these
patients at duplicated chromosomal segments with
molecular markers, although the parental origin of chro-
mosomal duplication is unknown. A phenotype that
defines cancer is measured for all subjects. A model will
be derived to distinguish between the genetic effects of
alleles inherited from the maternal (M) and paternal
parents (P).
Chromosome Duplication
Triploid Model
Consider a gene of interest A, with two alleles A and
a, on a chromosome (say chromosome 3). Figure
describes the process of a pair of normal chromosomes
that are duplicated into a triploid for a portion of
chromosome 3. For a normal diploid, the genotypes at
this gene may be AA, Aa, or aa. Considering parent-
specific origins of alleles, we use A|a, A|a, a|A, and a|
a to denote the configurations of these genotypes,
respectively, where the left- and right-side alleles of
the vertical lines represent two alleles from different
parents. Of these, configurations A|a and a|A are gen-
otypically observed as the same genotype Aa. When
the chromosomal segment that harbors this gene are
duplicated for only one single chromosome, triploids
with two copies from one parent and the third copy
from the other parent will result. It is possible that a
single chromosome derived from maternal and pater-
nal parents may both be duplicated, but with a differ-
ent frequency. Thus, through such a duplication, four
configurations in the normal diploid will form a total
of eight triploid configurations, which are classified
into four different genotypes:
(1) AAA including configurations AA|A, duplicated
from the left-side parent, and A|AA, duplicated from
the rightside parent, of configuration AA;
(2) AAa including configurations AA|a duplicated
from the left-side parent of configuration A|a and a|
AA duplicated from the right-side parent of config-
uration a|A;
(3) Aaa including configurations aa|A duplicated
from the left-side parent of configuration a|A and
A|aa duplicated from the right-side parent of config-
uration A|a;
(4) aaa including configurations aa|a, duplicated
from the left-side parent, and a|aa, duplicated from
the right-side parent, of configuration aa.
Let p and q (p + q = 1) are the allele frequencies of A
and a in the original population before chromosome
duplication. For a natural population at HWE, genotype
frequencies can be expressed as p2 for genotype AA, 2pq
for genotype Aa, and q2 for genotype aa.
Theorem
For an HWE diploid population, chromosome duplica-
tion operating on particular loci can violate the equili-
brium status of the population.
Proof: Let g and h denote a proportion of allele A and
a that is duplicated, respectively. Thus, of diploid geno-
type AA, a proportion g will become AAA, with the
remaining proportion 1 - g unduplicated. Similarly, a
proportion h and 1 - h will be aaa and aa after duplica-
tion for diploid genotype aa. Diploid genotype Aa will
have three possibilities, AAa with a proportion of g, Aaa
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with a proportion of h, and Aa with a proportion of 1 -
g - h. In a duplicated population purely composed of tri-
ploids, we will have allele frequencies for A and a,
respectively, as
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Figure 1 Diagram for chromosome duplication and the resulting changes of genotypes at an aneuploid gene A. Alleles in different
colors denote their parent-specific origins separated by the vertical lines.
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Similarly, we have the genotype frequency of triploid
aaa as
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Thus, unless g p pg qg qh= + +( )43 23 3 and
h q qh ph pg= + +( )43 23 3 , the duplicated population will be
at Hardy-Weinberg disequilibrium.
This theorem shows that traditional HWE theory
for population genetic studies will not be useful for
cancer gene identification. Meanwhile, this theorem
provides a foundation for deriving a statistical model
to conduct genome-wide association studies of
cancer.
Quantitative Genetic Parameters
The cancer patients sampled are purely composed of tri-
ploids at an aneuploid locus. Each patient is typed for
DNA-based markers at aneuploid loci and also pheno-
typed for a cancer trait. Let nk denote the observed num-
ber of triploid genotype k (k = 1 for AAA, 2 for AAa, 3
for Aaa, and 4 for aaa). The total number of patients
sampled is n nkk= =∑ 12 . It has proven that chromoso-
mal duplication may violate the Hardy-Weinberg equili-
brium of the population. Thus, genotype frequencies, Pk,
are expressed as the products of allele frequencies plus
disequilibrium parameters. Let D1 and D2 denote the
Hardy-Weinberg disequilibrium coefficients associated
with allele A and a, respectively, at the duplicated gene.
Thus, the frequencies of four genotypes can be expressed
in terms of allele frequencies and disequilibria (Table 1).
The same triploid genotype at the duplicated gene
may have different values when the expression of its
alleles depends on the origin of parents. For example,
triploid genotype AAA may be formed from normal
diploid genotype AA when either the maternally-(M)
or paternally-derived allele (P) is doubled. Thus, the
configuration of genotype AAA can be either AMAMAF
or AMAFAF, where the subscripts denote the parental
origin of alleles. Table 2 gives the genotypic values
(μk1, μk2) of two possible configurations of each tri-
ploid genotype. These genotypic values are partitioned
into eight different components, the overall mean (μ),
additive dominant genetic effect (a), dominance
genetic effects of AA over a (d) and A over aa (d’),
genetic imprinting effects due to different origins of
alleles (l), and interactions between the additive and
imprinting effects (Ial), the d dominance and imprint-
ing effects (Idl), and the d’ dominance and imprinting
effects (Id’l), respectively.
For each triploid genotype, the relative proportions of
two underlying configurations can be different, depend-
ing on the rate of the duplication of parent-specific
chromosomes. Let u and 1 - u be the proportions of the
duplication of allele A derived from the maternal and
paternal parents, respectively. Similarly, let v and 1 - v
be the proportions of the duplication of allele a derived
from the maternal and paternal parents, respectively
(Table 2). These proportions can be estimated from
genotype data.
Estimation
It is straightforward to estimate the frequency of a tri-
ploid genotype with genotype observations using
P
n
n
k
k
k
k
∧
=
=
∑ 14
, (1)
which is derived from a polynomial likelihood. The
EM algorithm is implemented to estimate the allele fre-
quencies ( p and q ) and HWD coefficients from the tri-
ploid genotype observations of the aneuploid population
sampled (Table 1). It is described as follows:
In the E step, we calculate the proportion of an allele
within a triploid genotype using
Table 1 The changes of genotypes and genotype frequencies after chromosomal duplication
Non-duplicated Duplicated
Genotype Frequency Duplication Genotype Frequency Observation
AA p2 ⇒ AAA P q D1
3
1= + n1
Aa 2pq ⇒ AAa P p q D D2
2
1 23 2= − +  n2
Aaa P pq D D3
2
2 13 2= − +  n3
aa q2 ⇒ aaa P q D4
3
2= + n4
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for allele a.
In the M step, the allele frequencies are then esti-
mated with the following equations:
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and the HWD coefficients are calculated by
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To estimate the duplication rate and genotypic values
for each configuration, we need to formulate a mixture
model because each triploid genotype contains two
unknown configurations. The likelihood of genotype
observations at the duplicated gene (Table 1) and phe-
notypic values (y) measured for all subjects is con-
structed as
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(k = 1, ..., 4; j = 1, 2) is the normal distribu-
tion of the phenotypic trait with mean μkj and variance
s2.
To obtain the maximum likelihood estimates (MLEs)
of the parameters, we implement the EM algorithm to
the likelihood (8). In the E step, the posterior probability
with which a subject i with a specific triploid genotype
Table 2 Genotypic values and proportions of different configurations of a triploid genotype at a duplicated gene
Duplicated
Genotype
Configuration Genetic Value Duplication
Rate
AAA A A A
A A A
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has a configuration j is calculated using
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In the M step, by solving the loglikelihood equations,
the parameters are estimated with the calculated poster-
ior probabilities, i.e.,
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A loop of the E and M steps is iterated between equa-
tions (9) and (10), (11), (12) and (13). Thus, the para-
meter estimates are obtained when the estimates
converge to stable values. The MLEs of genetic effects
can be obtained by solving a system of linear equations
given in Table 2, i.e.,
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Hypothesis Tests
How a duplicated gene deviates from Hardy-Weinberg
equilibrium can be tested by formulating the null
hypothesis as follows:
H D D0 1 2 0: ,= =
under which genotype frequencies can be estimated
from the estimated allele frequencies using equation (1).
The log-likelihood ratio calculated under the null and
alternative hypotheses follows a c2-distribution with 2
degrees of freedom. It is interesting to test the two
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disequilibria separately. Under the null hypothesis H0 :
D1 = 0. genotype frequencies are estimated using equa-
tion (1), but with a constraint P3 = p
3, in addition to
constraint P1+P2+P3+P4 = 1. Similarly, genotype fre-
quencies are estimated with a constraint P4 = q
3 for
testing whether D2 = 0.
Whether the duplicated gene is significantly associated
with cancer susceptibility can be tested using the null
hypothesis μkj ≡ μ for k = 1, ..., 4; j = 1, 2. The additive
effect and two types of dominance effects can be tested
jointly or separately by formulating the relevant null
hypotheses based on equations (14), (15), and (16). The
imprinting effect and its interactions with additive and
dominance effects can be tested by using the null
hypothesis H0 : l = 0, H0 : Ial = 0, H0 : Idl = 0, and H0
: Id’l= 0 constructed with equations (??), (18), (18), and
(19), respectively.
The model can also be used to test the significance of
duplication rate for a parentspecific chromosome by for-
mulating the null hypothesis H0 : u = 1 or H0 : v = 1.
This information helps to understand the genetic struc-
ture and evolutionary process of cancer risk.
Results
Simulation studies were used to investigate the statistical
properties of the model in terms of estimation precision,
power and false positive rates. We simulate a cancer
population of triploids for a portion of chromosome.
The allele frequencies at a triploid locus are p = 0.6
and q = 0.4. The HWD coefficients at this locus are
assumed as D1 = 0:08, D2 = 0:06. By assuming the dupli-
cation rates of 0.3 and 0.4 for two parental chromo-
somes, respectively, the distribution of four different
triploid genotypes AAA, AAa, Aaa, and aaa can be
simulated. The phenotypic values of cancer traits were
simulated by summing the additive, dominance, imprint-
ing, and their interaction effects given with particular
values and the errors of measurement within each tri-
ploid genotype following a normal distribution with var-
iance scaled by a heritability of 0.05, 0.10, and 0.20,
respectively. Different sample sizes, 400, 800, and 2,000
are considered.
The model was used to estimate allele frequencies,
HWD, parent-specific duplication rates, and genetic
effects for a cancer population (Table 3). As shown by
small sampling errors of the estimates, allele frequencies
can be precisely estimated with a modest sample size
(400). A larger sample size (say 800) is needed to pro-
vide precise estimation of two HWD coefficients D1 and
D2. Because duplication rates determine the mixture
proportions for each triploid genotype, their estimates
will be affected by the heritability level. If the cancer
trait has a larger heritability, then a sample size of 400
will provide good estimates of duplication rates. For a
less heritable trait, a large sample size (2000 or even
more) is needed for good estimation. The additive effect
Table 3 The estimates of population genetic parameters (p, u, v) and quantitative genetic parameters (a, d, d’, l, Ial,
Idl, Id’l) from simulated data with different sample size and heritability combinations
Sample Size H2 p u v a d d’ l Ial Idl Id’l
True Value 0:6 0:3 0:4 0:8 0:5 0:4 0:5 0:4 0:5 0:3
400 0.05 0:5973 0:2974 0:3389 0:9378 0:7793 0:5928 0:7974 0:6869 0:9731 0:5860
(0:0017) (0:0149) (0:0197) (0:0468) (0:1618) (0:1052) (0:0832) (0:0590) (0:2354) (0:1218)
0.1 0:6014 0:2803 0:3783 0:9252 0:5270 0:3571 0:6732 0:5647 0:6423 0:5066
(0:0016) (0:0183) (0:0190) (0:0404) (0:1548) (0:0662) (0:0664) (0:0447) (0:1854) (0:0750)
0.2 0:6016 0:2873 0:4139 0:8333 0:5436 0:3354 0:5116 0:4308 0:4066 0:3433
(0:0016) (0:0161) (0:0198) (0:0274) (0:0798) (0:0554) (0:0435) (0:0294) (0:1093) (0:0481)
800 0.05 0:5980 0:2463 0:3449 1:0740 0:6989 0:3363 0:8930 0:7510 0:6963 0:5266
(0:0012) (0:0154) (0:0227) (0:0576) (0:2247) (0:1128) (0:0909) (0:0626) (0:2694) (0:1153)
0.1 0:5993 0:2722 0:3783 0:8945 0:6552 0:4731 0:6004 0:5015 0:6375 0:5637
(0:0013) (0:0156) (0:0210) (0:0349) (0:1199) (0:0854) (0:0606) (0:0399) (0:1565) (0:0781)
0.2 0:5988 0:2809 0:3763 0:8756 0:4041 0:4281 0:5925 0:4799 0:3461 0:3254
(0:0011) (0:0166) (0:0194) (0:0275) (0:0781) (0:0444) (0:0379) (0:0253) (0:1035) (0:0466)
2000 0.05 0:6011 0:2428 0:3656 1:0367 0:7602 0:3605 0:7556 0:6271 0:8159 0:4858
(0:0007) (0:0165) (0:0209) (0:0622) (0:2001) (0:0852) (0:0995) (0:0647) (0:2416) (0:1019)
0.1 0:6008 0:2812 0:3805 0:8417 0:6676 0:4135 0:4838 0:4217 0:6970 0:5141
(0:0007) (0:0161) (0:0211) (0:0320) (0:1337) (0:0546) (0:0537) (0:0370) (0:1585) (0:0622)
0.2 0:6001 0:2860 0:3771 0:8103 0:5607 0:4490 0:4614 0:3758 0:6301 0:3942
(0:0008) (0:0132) (0:0185) (0:0153) (0:0511) (0:0383) (0:0297) (0:0195) (0:0699) (0:0331)
The numbers in parentheses are the sampling errors of the estimates.
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can be generally well estimated, but the estimates of the
dominant effects need much larger sample size. The
estimation precision of the imprinting effect seems to be
intermediate between that of the additive and dominant
effects. It is interesting to see that the additive ×
imprinting interaction effect can be better estimated
than the imprinting effect alone. It is hard to estimate
the interactions between the dominant and imprinting
effects unless an extremely large sample size (> 2000) is
used. Overall, the impact of heritability is large than
that of sample size, suggesting that it is important to
allocate limited resource to measure phenotypes pre-
cisely rather than increase sample size simply.
The power to detect the overall genetic effect and
imprinting effect was investigated. In general, the model
has great power for the identification of aneuploid loci
causing cancer. To achieve adequate power for imprint-
ing effect detection, a large sample size and/or large her-
itability is required. Overall, a sample size of 400 with a
heritability of 0.2 can reach power of over 0.75 for the
detection of imprinting effects. We also performed
simulation studies to examine the false positive rates for
detecting overall genetic effects and imprinting effects at
aneuploid loci. It appears that in each case the false
positive rates can be controlled to be below 5-10%.
Discussion
Over the past 100 years since Theodor Boveri hypothe-
sized that mitotic defects that result in tetraploidy pro-
mote oncogenesis [17], a tremendous concern has been
given to explore the genetic cause of tumorigenesis. It
has been partly established that aneuploidy has an effect
on proliferation and survival of tumors [5]. The recent
discovery of components of the mitotic checkpoint, as
well as the realization that many of the classic tumour
suppressors and oncogene products regulate mitotic
progression, has renewed interest in the role of aneu-
ploidy in tumorigenesis [10,15,16]. With the completion
of the human genome projects and HapMap project,
there is a pressing need for the development of statisti-
cal models for estimating the genetic effect of aneuploid
loci on cancer risk.
In this article, we present a statistical strategy for
detecting the genetic control of cancer traits through
genotyping aneuploids of cancer cells. The model pro-
posed presents two novelties. First, it has for the first
time integrated the latest discovery of cancer genetic
studies with statistical principles and directly pushed the
modeling effort of cancer gene identification at the fron-
tier of cancer biology. The experimental design used is
founded on biologically relevant hypotheses from which
data can be collected in an effective way. The derived
closed forms for the EM algorithm to estimate various
parameters will provide an efficient computation for any
data set. Second, the model capitalizes on traditional
quantitative genetic theory, allowing the partition of
overall genetic control into different components. Parti-
cularly, we are able to estimate and test the effect of
genetic imprinting on cancer risk [18,19] and, thus,
draw a detailed picture of genetic control triggered from
different parental chromosomes. The model can also
characterize the interactions of additive and dominant
effects with imprinting effects, helping to gain a better
insight into the complexity of the genetic architecture of
cancer.
We performed computer simulation to examine the
statistical properties of the model. Results from simula-
tion studies were investigated, from which an appropri-
ate sample size is determined for a cancer trait with a
particular heritability. Analyses of model power and
false positive rates validated the possible usefulness of
the model when practical data sets are available.
Through a simple mathematical proof, we found that
the Hardy-Weinberg equilibrium of an original popula-
tion can be destroyed when some chromosomes are
duplicated.
The idea of the model can be extended to several
more complicated situations. First, the aneuploidy con-
trol of cancer may be derived from high-order aneu-
ploid, such as tetraploids. A high-order polyploid not
only contain more allelic combinations, but also a more
amount of missing data due to the duplication of differ-
ent chromosomes with unknown parental origins. To
model the tetraploidy control of cancer, a more sophisti-
cated algorithm is required to obtain efficient estimates
of parameters. Second, different aneuploid loci responsi-
ble for cancer traits may be associated in the duplication
population and interact in a coordinated manner. Mod-
eling of multi-locus associations and multi-locus epista-
sis will deserve a further investigation although these
pieces of information can better explain the genetic var-
iation of cancer than single loci. Third, other factors,
such as sex, race, and life style, also contribute to can-
cer. It is crucial to incorporate these factors and study
the effects of each of them and their interactions with
genes in tumorigenesis.
Conclusion
We have derived a new statistical model for identifying
genetic loci that control quantitative phenotypes of
aneuploidy cancer through a genome-wide association
study. We integrate quantitative genetic principles into
the model, allowing the estimation of different types of
genetic effects. The new model can generate a series of
hypotheses tests about the explanation of the genetic
control mechanisms of cancer through aneuploid loci.
Although our model was explored merely from a theo-
retical perspective, specific experiments should be
Li et al. BMC Cancer 2010, 10:346
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readily launched to collect the data according to the
genetic design suggested. By analyzing such data, the
new model should be able to uncover unique results,
facilitating our understanding of how aneuploid pro-
cesses are linked with cancer through genetic
mediations.
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